TAKE Solutions Limited (TAKE.NS)
INR 8.42
(1.94%)
INR 8.42
(1.94%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 7.96 Million INR | 2.56% |
| 2022 | 7.76 Million INR | 19.58% |
| 2021 | 6.49 Million INR | 7.27% |
| 2020 | 6.05 Million INR | -82.32% |
| 2019 | 34.22 Million INR | -80.51% |
| 2018 | 175.54 Million INR | 4.92% |
| 2017 | 167.31 Million INR | -3.77% |
| 2016 | 173.86 Million INR | -19.3% |
| 2015 | 215.45 Million INR | -6.24% |
| 2014 | 229.8 Million INR | 33.31% |
| 2013 | 172.38 Million INR | 11.44% |
| 2012 | 154.68 Million INR | -14.75% |
| 2011 | 181.45 Million INR | 52.64% |
| 2010 | 118.87 Million INR | 47.21% |
| 2009 | 80.74 Million INR | 237.14% |
| 2008 | 23.95 Million INR | 72.52% |
| 2007 | 13.88 Million INR | -4.27% |
| 2006 | 14.5 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 9.15 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 7.96 Million INR | 2.56% |
| 2023 Q4 | 7.96 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q2 | 6.64 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 7.76 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 7.76 Million INR | 19.58% |
| 2021 Q2 | 6.76 Million INR | 0.0% |
| 2021 Q4 | 6.49 Million INR | 0.0% |
| 2021 FY | 6.49 Million INR | 7.27% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 6.05 Million INR | 0.0% |
| 2020 Q2 | 8.15 Million INR | 0.0% |
| 2020 FY | 6.05 Million INR | -82.32% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 38.37 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 34.22 Million INR | 0.0% |
| 2019 FY | 34.22 Million INR | -80.51% |
| 2018 Q2 | 184.65 Million INR | 0.0% |
| 2018 FY | 175.54 Million INR | 4.92% |
| 2018 Q4 | 175.54 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 175.89 Million INR | 0.0% |
| 2017 FY | 167.31 Million INR | -3.77% |
| 2017 Q4 | 167.31 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 173.86 Million INR | 0.0% |
| 2016 Q2 | 211.76 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 173.86 Million INR | -19.3% |
| 2015 FY | 215.45 Million INR | -6.24% |
| 2015 Q4 | 215.45 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q2 | 274.92 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2014 Q2 | 216.45 Million INR | 0.0% |
| 2014 FY | 229.8 Million INR | 33.31% |
| 2014 Q4 | 229.8 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 FY | 172.38 Million INR | 11.44% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 181.28 Million INR | 0.0% |
| 2013 Q4 | 172.38 Million INR | 0.0% |
| 2012 FY | 154.68 Million INR | -14.75% |
| 2012 Q4 | 154.68 Million INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 152.82 Million INR | 0.0% |
| 2011 FY | 181.45 Million INR | 52.64% |
| 2011 Q4 | 181.45 Million INR | 0.0% |
| 2010 FY | 118.87 Million INR | 47.21% |
| 2009 FY | 80.74 Million INR | 237.14% |
| 2008 FY | 23.95 Million INR | 72.52% |
| 2007 FY | 13.88 Million INR | -4.27% |
| 2006 FY | 14.5 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Biocon Limited | 49.43 Billion INR | 99.984% |
| Blue Jet Healthcare Limited | 1.29 Billion INR | 99.387% |
| Concord Biotech Limited | 2.07 Billion INR | 99.617% |
| Dishman Carbogen Amcis Limited | 8.82 Billion INR | 99.91% |
| Jubilant Ingrevia Limited | 9.41 Billion INR | 99.915% |
| Lyka Labs Limited | 95.71 Million INR | 91.684% |
| Panacea Biotec Limited | 1.77 Billion INR | 99.553% |
| Piramal Pharma Limited | 21.75 Billion INR | 99.963% |
| SMS Lifesciences India Limited | 812.1 Million INR | 99.02% |
| Supriya Lifescience Limited | 852.49 Million INR | 99.066% |
| Syngene International Limited | 2.38 Billion INR | 99.666% |
| Zota Health Care Limited | 537.66 Million INR | 98.52% |